This Guidance Document provides companies with direction on implementing legitimate, bona fide training and education programs.
AdvaMed publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
AdvaMed urged CDC to recognize the critical role evidence-based and FDA-approved/cleared devices can and should play in improving pain management and reducing opioid-related harms.
AdvaMed Statements from Centers for Medicare and Medicaid Services Listening Sessions on Transitional Coverage of Emerging Technologies
During two listening sessions, AdvaMed provided responses to a set of questions posed by CMS on the parameters for a new TCET program, including the types of guidance provided by…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed Responds to HHS Office of the National Coordinator Request for Information on Electronic Prior Authorization Standards
AdvaMed submitted a response to a Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) Request for Information (RFI) on electronic prior…
AdvaMed Responds to White House Office of Science and Technology Policy Request for Information on Strengthening Community Health Through Technology
AdvaMed submitted a response to a White House Office of Science and Technology Policy (OSTP) Request for Information (RFI) on Strengthening Community Health Through Technology.
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
AdvaMed Responds to U.S. House of Representatives Health Futures Task Force, Subcommittee on Treatments Request for Information on Fostering Patient Access to Life-Saving Cures
AdvaMed submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Subcommittee on Treatments (Subcommittee on Treatments) Request for Information (RFI) on information to help foster patient…